DT
Therapeutic Areas
CardioDiagnostics Inc. Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Epi+Gen CHD | 3-Year Coronary Heart Disease Event Risk Assessment | Commercial |
| PrecisionCHD | Detection of Coronary Heart Disease | Commercial |
| Population Health Solutions | Employer & Payer Wellness Programs | Commercial |
| Biopharma Solutions | Clinical Trial Enrichment & Biomarker Discovery | Development |
Leadership Team at CardioDiagnostics Inc.
DM
Dr. Meesha Dogan
Chief Executive Officer & Co-Founder
DR
Dr. Rob Philibert
Chief Medical Officer & Co-Founder